BioAtla, Inc (BCAB) insider trading

Every open-market stock purchase and sale by BioAtla, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Sylvia McBrinn (Director), $9.3K, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.74 on Aug 28, 2026.

Recent BCAB insider trades

DateInsiderTradeValue
Aug 31, 2026Jay M Short Phd (CEO)Sold (not open market)$438
Aug 31, 2026Eric Sievers (C-suite exec)Sold (not open market)$226
Aug 31, 2026Christian Vasquez (CFO)Sold (not open market)$120
May 31, 2026Jay M Short Phd (CEO)Sold (not open market)$1K
May 31, 2026Eric Sievers (C-suite exec)Sold (not open market)$527
May 31, 2026Christian Vasquez (CFO)Sold (not open market)$322
Mar 12, 2026Jay M Short Phd (CEO)Sold (not open market)$107
Mar 11, 2026Eric Sievers (C-suite exec)Sold (not open market)$61
Mar 11, 2026Christian Vasquez (CFO)Sold (not open market)$30
Mar 11, 2026Jay M Short Phd (CEO)Bought (not open market)—
Mar 10, 2026Christian Vasquez (CFO)Bought (not open market)—
Mar 10, 2026Eric Sievers (C-suite exec)Bought (not open market)—
Feb 28, 2026Jay M Short Phd (CEO)Sold (not open market)$1.9K
Feb 28, 2026Eric Sievers (C-suite exec)Sold (not open market)$776
Feb 28, 2026Richard A Waldron (CFO)Sold (not open market)$674
Feb 28, 2026Christian Vasquez (CFO)Sold (not open market)$445
Nov 30, 2025Jay M Short Phd (CEO)Sold (not open market)$5.7K
Nov 30, 2025Eric Sievers (C-suite exec)Sold (not open market)$2.5K
Nov 30, 2025Richard A Waldron (CFO)Sold (not open market)$2.1K
Nov 30, 2025Christian Vasquez (Insider)Sold (not open market)$1.4K

Who's trading BCAB

Get free alerts when an insider at BioAtla, Inc files a new trade →